Respiratory illness activity is currently considered "high" in the United States, according to the CDC. In one state, it is ...

Newsweek has created a map showing states where respiratory syncytial virus (RSV) cases are surging.

Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity -; primarily organ transplant recipients who take immunosuppressive medications to reduce the risk of ...

Feeling ill after that Christmas or New Year's Eve party? If could be RSV. But how can you know for sure? Here are the ...

The adjuvanted RSV prefusion F protein-based vaccine RSVPreF3-AS01E Arexvy was first FDA approved for older adults in May ...

RSV prevention among children, including nirsevimab and the maternal RSVpreF vaccine, may be associated with a reduction in ...

Respiratory Syncytial Virus Prefusion F (RSVpreF) vaccination is effective against RSV-related lower respiratory tract ...

More Americans believe in the effectiveness of vaccines developed to protect newborns and seniors against respiratory ...

The study followed 38 immunocompromised adults, aged 64 to 72, who received either the Arexvy or Abrysvo RSV vaccine. Researchers found that people aged 60 and older who are immunocompromised ...

Background: Research from multiple regions indicates that Coronavirus disease of 2019 pandemic has altered the ...